EichorEICHOR
Study identifier: NCT06849882 Synced from ClinicalTrials.gov · August 08, 2026
● Study status: Recruiting

Dubousset Functional Test: an Investigation of Its Validity and Reliability in Individuals with Multiple Sclerosis

Condition: MS (Multiple Sclerosis)  ·  Sponsor: Inonu University

PhaseN/A
Planned participants33
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNoCheck eligibility criteria ↓
WhereKayseri, Kayseri, Turkey (Türkiye)

Interested? Contact the study team ↓

Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.

About this study

Multiple sclerosis (MS) is an autoimmune disease characterized by neuroinflammation and neurodegeneration in the central nervous system. The disease affects the white matter, cortex and deep gray matter of the central nervous system and is characterized by inflammatory-demyelinating lesions and neuronal/axonal degeneration. Demyelination associated with these lesions and the accompanying axonal degeneration are responsible for neurological disability in MS. There are many scales and mobility and functional performance tests in the literature to assess balance, such as the Sit Reach Test, Timed Up and Go (TUG) test, Tinetti Performance Oriented Mobility Assessment (POMA), Berg Balance Scale (BBS) (5) and Balance Evaluation System Test (BESTest). The most appropriate balance assessment scales for individuals with MS are those that assess static and dynamic sitting balance while standing and dynamic balance only. Since balance in individuals with MS is a dynamic process that changes gradually, new measurement methods that can record these changes and determine the appropriate treatment for these variables are needed. The Dubousset Functional Test (DFT) was developed by Dr. Jean Dubousset as a four-component practical assessment to evaluate the physical function and balance capacity of individuals with spinal deformity. The DFT consists of four components: getting up from an armless chair and walking 5 meters forward and backward, ascending and descending steps, transition from …

This description comes directly from the study's public registry record.

Talk to the study team

betül erciyes university  ·  +905061514082  ·  bonerdiir@gmail.com

There is no obligation to join — the study team can answer your questions about taking part.

Always discuss trial participation with your own doctor first.

Full eligibility criteria (exactly as the study team wrote them)

Inclusion Criteria: * Being diagnosed with MS, * Over 18 years of age and under 65 years of age, * To be able to balance independently in standing position. * EDSS score of 3.5 and below * At the appropriate cognitive level to adapt to the tests to be performed in the study, * Completed primary school level, Exclusion Criteria: * Relapse within the last 30 days, * Loss of balance or gait disturbance affected by a condition other than MS, * Being pregnant for female individuals, * An attack of optic neuritis in the last month * Individuals who are unable to perform the task due to sensory, cognitive or other problems will be excluded.

Reproduced word-for-word from the public registry record — the study team can answer questions about it.

Locations (1)

Erciyes UniversityKayseri, Kayseri, Turkey (Türkiye)Recruiting

More studies in these areas

This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.

Kayseri

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Look up another condition
Look up another city
Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →